Shares of Summit Therapeutics (NASDAQ:SMMT) traded higher for the second straight session on Thursday after Cantor Fitzgerald ...

Adding pembrolizumab to docetaxel did not significantly improve outcomes in previously treated patients with mCRPC.

Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more effectively.

Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.

The US Food and Drug Administration (FDA) has granted clearance to CureVac's investigational new drug application (IND) for the open-label Phase I trial of CVHNLC in individuals with squamous ...

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary ...

The firm will evaluate CVHNLC in combination with Keytruda as a first-line and first-line maintenance treatment in NSCLC.

Immunotherapy is key for triple-negative breast cancer, but a new study finds Black women are receiving it less often than White women.

Enfortumab vedotin plus pembrolizumab is more effective than chemotherapy as first-line treatment for metastatic urothelial cancer, data suggest.

CureVac (CVAC) announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for a Phase 1 clinical ...

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary bladder and the upper part of the urethra. In the vast majority of cases, ...

NIH researchers discovered that a new form of personalized cancer immunotherapy dramatically improved the treatment’s ...